Nanoptima
1 known investors
Nanoptima develops drug delivery technologies for ophthalmic applications, focusing on biomaterial-based solutions for retinal and eye diseases. The company draws on deep pharma and biotech expertise to advance formulation science and delivery mechanisms for pharmaceutical treatments.
Founders & leadership
NW
Ned WakemanCEO
Board
SF
Stephen FromChairman
Investors · 1
Frequently asked questions
- What does Nanoptima do?
- Nanoptima develops drug delivery technologies for ophthalmic applications, focusing on biomaterial-based solutions for retinal and eye diseases. The company draws on deep pharma and biotech expertise to advance formulation science and delivery mechanisms for pharmaceutical treatments.
- Who are Nanoptima's investors?
- Nanoptima's investors include Deepbridge Capital.